BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.01 0.00 (-27.78%)
As of: Oct 21, 2026 · 12:26 PM EDT

BioXcel Therapeutics (BTAIQ) Operating Margin (2018 - 2026)

Updated

BioXcel Therapeutics' Operating Margin came in at -5600.55% for Q2 2026, up 7609.45 percentage points from -13210.00% a year earlier but down 637.93 percentage points from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Operating Margin (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioXcel Therapeutics reported Operating Margin of -6054.72%, down 94.23 percentage points year-over-year; for FY2025, it came in at -7859.97%, down 4892.40 percentage points from FY2024.

  • Operating Margin carries a three-year change of +34712.03 percentage points (FY2022 to FY2025).
  • Going back by year, Operating Margin was -2967.56% in FY2024 (+9480.41 pp), -12447.97% in FY2023 (+30124.03 pp) and -42572.00% in FY2022.
  • The five-year range for quarterly Operating Margin is -28459.85% (Q3 2022) to -1566.67% (Q2 2024).
  • Year-over-year, Operating Margin increased in four of the last eight quarters, with an average year-over-year change of -491.29 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in Q1 2024 (a gain of 20701.68 percentage points), and the weakest in Q2 2025 (a drop of 11643.33 percentage points).
  • Business Quant data shows BTAIQ's Operating Margin at -4962.62% (Q1 2026), -4016.41% (Q4 2025) and -14518.37% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn 28.21%
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn 37.86%
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 20.57%
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn -133.21%
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 28.37%
10 BioXcel Therapeutics 378,750.01 -94.23 Mn 160,000.00 -5,600.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5,600.55%
Mar 31, 2026 -4,962.62%
Dec 31, 2025 -4,016.41%
Sep 30, 2025 -14,518.37%
Jun 30, 2025 -13,210.00%
Mar 31, 2025 -6,011.31%
Dec 31, 2024 -2,866.94%
Sep 30, 2024 -7,146.26%
Jun 30, 2024 -1,566.67%
Mar 31, 2024 -4,151.72%
Dec 31, 2023 -5,285.90%
Sep 30, 2023 -14,163.34%
Jun 30, 2023 -11,469.15%
Mar 31, 2023 -24,853.40%
Dec 31, 2022 -22,224.37%
Sep 30, 2022 -28,459.85%
Sep 30, 2021 -2,681,200.00%
Jun 30, 2020 -133,968.75%
Mar 31, 2020 -17,642.35%
Dec 31, 2019 -6,096.38%
API Access

BioXcel Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY